scholarly journals 303: Anxiety and depression screening: A five-year experience in a southeastern pediatric CF program

2021 ◽  
Vol 20 ◽  
pp. S146
Author(s):  
S. Szentpetery ◽  
K. Foil ◽  
P. Flume ◽  
L. Christon
2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1114.2-1114
Author(s):  
M. Letaeva ◽  
M. Koroleva ◽  
J. Averkieva ◽  
O. Malyshenko ◽  
T. Raskina

Objectives:to assess the frequency of occurrence of the anxiety-depressive spectrum in patients with rheumatoid arthritis and ankylosing spondylitis.Methods:A survey was conducted of 44 patients aged from 21 to 57 years (average age - 42.3 ± 6.7 years), who were treated at GAUZ KO OKGVV. All patients had a verified diagnosis of RA and AS according to the ACR criteria and received treatment with basic drugs. The control group consisted of 40 people comparable in age and sex, without concomitant pathology of RA and AS.The depression screening card, the subjective well-being scale, and the hospital anxiety and depression scale (HADS) were used to assess and detect anxiety-depressive syndrome. The assessment of the condition is carried out over the last 2 weeks, which corresponds to the temporary diagnostic criterion for depression.The Depression Screening Scale is a 35-item self-questionnaire that assesses 7 categories of signs: sleep and appetite disorders, anxiety, emotional instability, cognitive impairment, loss of self, guilt, and suicidal tendencies. A total score of 65 and above indicates a high likelihood of depression.The Subjective Well-Being Scale is a psychodiagnostic screening tool for measuring the emotional component of subjective well-being or emotional comfort.Hospital Anxiety and Depression Scale Zigmond A.S., Snaith R.P. was developed for the primary detection of depression and anxiety in a general medical practice. The HADS scale consists of 14 statements with 4 possible answers and includes two parts: anxiety and depression. The sum of points of 8 or more is regarded as “subclinically expressed anxiety / depression”, 11 or more points - “clinically expressed anxiety / depression”.Results:According to the results of the depression screening questionnaire, 34 (77.3%) patients with RA and AS showed signs of depression, while in the control group only 6 (15%) patients tested positive for the presence of depressive disorders. According to the data obtained when assessing the scale of well-being in the main group, 26 (59.1%) patients showed signs of emotional discomfort (the indicator was 80% or more), in the control group - in 6 (15%). Using the hospital scale of anxiety and depression HADS, anxiety-depressive syndrome was detected in 36 (81.8%) patients with RA and AS: 16 (44.4%) patients had anxiety, 20 (55.6%) - depression, of them, subclinically expressed anxiety and depression were observed in 10 (27.7%) and 12 (33.3%) people, respectively. Anxiety-depressive syndrome in the control group, according to the HADS questionnaire, was detected only in 8 (20%) patients, of whom 4 (10%) patients had subclinical anxiety and 4 (10%) had signs of depression. No clinically pronounced anxiety and depression were registered in the control group.Conclusion:In most patients with rheumatoid arthritis and ankylosing spondylitis, anxiety-depressive disorders have been identified, which can directly affect both the course of the disease itself and the development of various complications. Timely diagnosis of mental disorders and close cooperation of rheumatologists, psychiatrists and psychologists in the selection of adequate therapy can improve the course and prognosis of the disease.Disclosure of Interests:None declared


2012 ◽  
Vol 25 (1) ◽  
pp. 82-87 ◽  
Author(s):  
Nikolaos Samaras ◽  
François R. Herrmann ◽  
Dimitrios Samaras ◽  
Pierre-Olivier Lang ◽  
Alessandra Canuto ◽  
...  

ABSTRACTBackground: We currently use the depression subscale (HADD) of the Hospital Anxiety and Depression Scale (HADS) for depression screening in elderly inpatients. Given recent concerns about the performance of the HADD in this age group, we performed a quality-control study retrospectively comparing HADD with the diagnosis of depression by a psychiatrist. We also studied the effect of dementia on the scale's performance.Methods: HADS produces two 7-item subscales assessing depression or anxiety. The HADD was administered by a neuropsychologist. As “gold standard” we considered the psychiatrist's diagnosis based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria. Patients older than 65 years, assessed by both the HADD and the psychiatrist, with a clinical dementia rating (CDR) score lower than 3, were included. The effect of dementia was assessed by forming three groups according to the CDR score (CDR0–0.5, CDR1, and CDR2). Simple and multiple logistic regression models were applied to predict the psychiatrist's depression diagnosis from HADD scores. Areas under the receiver operating characteristics curve (AUC) were plotted and compared by χ2 tests.Results: On both univariate and multiple analyses, HADD predicted depression diagnosis but performed poorly (univariate: p = 0.009, AUC = 0.60 (95% confidence interval (CI) = 0.53–0.66); multiple: p = 0.007, AUC = 0.65 (95% CI = 0.58–0.71)), regardless of cognitive status. Because mood could have changed between the two assessments (they occurred at different points of the hospital stay), the multiple analyses were repeated after limiting time interval at 28, 21, and 14 days. No major improvements were noted.Conclusion: The HADD performed poorly in elderly inpatients regardless of cognitive status. It cannot be recommended in this population for depression screening without further study.


2021 ◽  
Vol 118 ◽  
pp. 107943
Author(s):  
Heidi M. Munger Clary ◽  
Mingyu Wan ◽  
Kelly Conner ◽  
Gretchen A. Brenes ◽  
James Kimball ◽  
...  

2020 ◽  
Vol 19 (5) ◽  
pp. 8-16
Author(s):  
A.A. Kirpichenka ◽  
◽  
A.N. Baryshau ◽  

Скрининг тревоги и депрессии у пациентов в общемедицинской амбулаторной практике является весьма насущной проблемой современной медицины. В данном литературном обзоре авторы обобщают и систематизируют разрозненные и противоречивые данные относительно скрининга тревожных и депрессивных расстройств, а также вносят предложения по его оптимизации в общей врачебной практике. В статье сделан акцент на актуальные проблемы по организации скрининга и основные препятствия, которые мешают его эффективному внедрению в общую врачебную практику. Рассматриваются проблемные вопросы гипердиагностики тревожно-депрессивных расстройств и последующего неадекватного лечения, психиатрическая стигма и дополнительные трудозатраты врачей в ходе амбулаторного приёма. Особое внимание обращается на необходимость дальнейшей оптимизации скрининга тревоги и депрессии для повышения эффективности оказания психиатрической и психотерапевтической помощи пациентам в амбулаторно-поликлинической сети. По мнению авторов, для этого необходимо в ближайшее время осуществить ряд изменений на законодательном уровне.


2020 ◽  
Author(s):  
Abdilahi Yousuf ◽  
Ramli Musa ◽  
Muhammad Lokman Md. Isa ◽  
Siti Roshaidai Mohd Arifin

AbstractIntroductionIntegration of related health services, such as screening of depression in HIV care is crucial for improving the quality of care and enhancing the use of scarce resources in developing countries. However, commonly these interrelated health services are commonly provided separately and there are many missed opportunities. Little is known about the client-related non-implementation issues. This study aims at examining the acceptability of anxiety and depression screening among women living with HIV.Material and methodsThis was a facility based cross-sectional study which included women living with HIV attending two hospitals in Jijiga town, Ethiopia. The study participants were identified using systematic random sampling method. An exit interview was conducted with the use of a pretested questionnaire. The gathered data was analysed using SPSS version 23 and multivariate logistic regression model was used to determine factors associated with the factors associated with the acceptance of anxiety and depression screening.ResultsA total of 409 women participated in this study. Though, only 115 (28.1%) were aware about the existence of anxiety and depression screening, 357 (87.3%) accepted to receive the screening for anxiety and depression. Requisite of partner approval was the most common reason for not accepting the screening of anxiety and depression 21 (40.4%). When used multivariate logistic regression model; holding college level education, divorced and were living without partner, being self employed by occupation, aware of the existing screening service, source of information from health care providers and history of previous screening were significantly associated with acceptance of depression screening.ConclusionThis research has shown that women participant living with HIV were willing to undergo the screening for depression, hence future interventions should focus on the integration of mental health screening in HIV clinical setup.


2016 ◽  
Vol 32 ◽  
pp. 177-181 ◽  
Author(s):  
Aaron Conway ◽  
Judith Sheridan ◽  
Joanne Maddicks-Law ◽  
Paul Fulbrook ◽  
Chantal F. Ski ◽  
...  

2008 ◽  
Vol 8 (3) ◽  
pp. 182-188 ◽  
Author(s):  
Wayne Katon ◽  
Joan Russo ◽  
Laura Richardson ◽  
Elizabeth McCauley ◽  
Paula Lozano

Sign in / Sign up

Export Citation Format

Share Document